FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

British Journal of Cancer, Published online: 06 November 2020; doi:10.1038/s41416-020-01140-9FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

http://feeds.nature.com/~r/bjc/rss/current/~3/DVUgywA48UA/s41416-020-01140-9

Source: British Journal of Cancer - November 6, 2020 Category: Cancer & Oncology Authors: Volker Heinemann Ludwig Fischer von Weikersthal Thomas Decker Alexander Kiani Florian Kaiser Salah-Edin Al-Batran Tobias Heintges Christoph Lerchenm üller Christoph Kahl Gernot Seipelt Frank Kullmann Markus Moehler Werner Scheithauer Swantje Held Lisa Mi Source Type: research